Bioderma

Bioderma is a French dermatological skincare brand founded in 1977 by pharmacist-biologist Jean-Noël Thorel. It is the dermatology-focused brand within NAOS, the privately held French group that also owns Institut Esthederm and Etat Pur. Bioderma’s headquarters and principal design and manufacturing facilities are associated with Aix-en-Provence in southern France, while the brand is distributed internationally through pharmacies, drugstores, dermatology channels, selected beauty retailers and e-commerce. The brand was created within the scientific and entrepreneurial project that later became NAOS. Thorel’s approach was to combine pharmaceutical and biological thinking with cosmetic formulation, treating the skin as a living ecosystem rather than as a passive surface to be aggressively corrected. This philosophy was later formalized within NAOS as “ecobiology,” an approach that seeks to understand the skin’s biological mechanisms, support its natural functions and limit unnecessary formulation complexity. Bioderma applies this positioning to skin cleansing, hydration, barrier support, acne-prone skin, pigmentation, sun protection, scalp care, pediatric care and recovery of irritated or compromised skin. Bioderma’s most important commercial breakthrough was the development of micellar cleansing technology in the 1990s and the launch of Sensibio H2O, originally associated with the Créaline name in some markets. The product helped establish micellar water as a mainstream skincare category while retaining a pharmacy and sensitive-skin identity. Sensibio H2O is positioned for sensitive and reactive skin and has become the brand’s best-known global offering. Its success gave Bioderma a recognizable entry point into facial cleansing and helped support expansion into broader dermatological routines. The portfolio is organized primarily by skin concern and biological need. Sensibio addresses sensitive and intolerant skin; Atoderm focuses on dry, very dry and atopic-prone skin; Sébium targets combination, oily and blemish-prone skin; Hydrabio addresses dehydrated skin; Cicabio supports irritated or damaged skin; Photoderm covers sun protection; Nodé serves scalp and hair-care needs; ABCDerm is designed for babies and children; and Pigmentbio addresses uneven tone and hyperpigmentation. Additional products span facial cleansers, moisturizers, emollients, serums, body care, lip care, shower products and specialized dermatological treatments. The brand’s pharmacy orientation is reflected in its emphasis on dermatological testing, high-tolerance formulas, skin-barrier support and professional recommendation. Bioderma communicates through skin biology and efficacy rather than luxury or celebrity-led beauty positioning. Its packaging, product naming and educational materials generally organize the range around recognizable dermatological conditions and routines, making the brand accessible to consumers seeking targeted care without abandoning a mass-market distribution model. Bioderma remains part of NAOS’s integrated model. NAOS states that its principal products are designed and manufactured in France at NAOS Les Laboratoires in Aix-en-Provence, using quality and testing practices inspired by pharmaceutical laboratories. The group has expanded internationally through subsidiaries and distribution partnerships, and NAOS reports a presence in more than 100 countries. In 2018, Jean-Noël Thorel transferred his shares in NAOS to the Jean-Noël Thorel Foundation, reinforcing the group’s stated model of reinvesting profits in the company and in health and human-development initiatives rather than distributing conventional shareholder dividends. Bioderma’s current identity therefore combines three elements: a strong pharmacy and dermatology heritage, a scientific narrative centered on the biology of the skin, and a globally recognizable portfolio led by Sensibio H2O. It competes in the dermocosmetics sector alongside brands such as La Roche-Posay, Avène, Eucerin and CeraVe, but differentiates itself through NAOS’s ecobiological philosophy, concern-based product architecture and long-standing association with sensitive-skin cleansing.

Bioderma originated in France in 1977 through the work of Jean-Noël Thorel, a pharmacist and biologist who sought to bring biological and pharmaceutical reasoning into skincare. Before establishing his own venture, Thorel worked in pharmacy and in the pharmaceutical industry. In May 1977 he became an independent designer and inventor, initially working from a warehouse near Rungis with limited capital. His early network of scientists, dermatologists, pharmacists and pharmaceutical laboratories allowed him to develop products intended to combine a biological function within the epidermis with a cosmetic function at the skin surface. The first Bioderma products were created alongside the CEREDAP research center, whose name referred to applied research in aesthetics and dermatology. This early research structure established the brand’s long-term identity: products were to be developed from an understanding of skin biology and dermatological needs rather than from purely cosmetic presentation. The same entrepreneurial platform also gave rise to Institut Esthederm in 1978, creating the foundations of what later became the NAOS group. In 1985, DIPTA was created to support research, industrialization and manufacturing for Bioderma and Institut Esthederm. NAOS later consolidated its design and manufacturing activities in southern France. NAOS states that its laboratory has been based in Aix-en-Provence since 1988 and that its products are designed and manufactured there under standards inspired by pharmaceutical laboratories. This vertical organization allowed the group to retain control over formulation, raw-material testing, production and regulatory processes. Bioderma’s decisive commercial turning point came in 1995 with the development of micellar technology. The technology enabled cleansing and makeup removal through a formulation designed to be gentle on the skin, and it led to the creation of Sensibio H2O, known in some historical markets as Créaline H2O. The product helped create and popularize the micellar-water category while establishing Bioderma as a specialist in sensitive-skin cleansing. Sensibio H2O became the brand’s global signature product and remains central to its identity. The micellar-water breakthrough was part of a broader period of innovation within NAOS. The group describes its history as including more than 70 patent filings in earlier corporate materials and later reports a larger portfolio of patent families. Its scientific platform expanded from cleansing into skin-barrier support, hydration, acne care, sun protection, pediatric dermatology, scalp care and repair of irritated skin. Bioderma organized these applications into concern-based ranges such as Atoderm, Sébium, Hydrabio, Photoderm, Nodé, ABCDerm and Cicabio. Internationalization accelerated in 2001 when NAOS opened its first foreign subsidiary in Italy. The group subsequently established or developed more than 40 affiliates and expanded distribution across Europe, North America, Latin America, Asia-Pacific, the Middle East, Africa and Oceania. This expansion enabled Bioderma to operate simultaneously as a professional pharmacy brand and as a consumer-recognized dermocosmetics label. In different countries, the brand’s products have been distributed through pharmacies, drugstores, dermatology channels and online retailers, with product names and regulatory classifications sometimes varying by market. In 2011, NAOS launched Etat Pur, a third brand built around personalized and biomimetic skincare. In 2016, the activities of Bioderma, Institut Esthederm and Etat Pur were merged into a more cohesive company structure called NAOS. Bioderma remained the dermatology-oriented pillar of the group, while Institut Esthederm focused on aesthetic skincare and Etat Pur on individualized active-ingredient care. A major ownership and governance change occurred in 2018, when Jean-Noël Thorel donated his shares in NAOS to the Jean-Noël Thorel Foundation. NAOS presents this structure as an altruistic ownership model under which profits are reinvested into the company or used to support health and human-development projects. The change did not alter Bioderma’s status as a privately controlled brand, but it strengthened the group’s distinction from conventional publicly traded beauty companies. During the 2020s, Bioderma continued to extend its product architecture while NAOS promoted ecobiology as the shared philosophy of its brands. The company’s communications emphasize the skin as a living ecosystem, the importance of preserving natural biological functions and the development of products based on needs identified by dermatologists and consumers. Sustainability-related activities have also become more visible at group level, including work on biodegradable rinse-off formulas, assessment of sunscreen ingredients for aquatic impact and support for marine-ecosystem initiatives. Bioderma’s history is therefore defined less by acquisitions or public-market events than by the gradual development of a privately owned dermatological platform. Its major turning points were the creation of the first products in 1977, the establishment of research and manufacturing capabilities, the 1995 micellar-water innovation, international expansion from 2001 onward, integration into NAOS in 2016 and the foundation-based ownership model adopted in 2018. The brand’s present position rests on the continuing combination of pharmacy credibility, skin-biological research, French manufacturing and a broad portfolio designed around specific skin conditions.

• 2023

  Expansion of NAOS scientific platform

  [8]Creation of DIPTAnaos.com

  NAOS highlighted new scientific work and the launch of Age Proteom Advanced Serum at group level, illustrating continued investment in skin biology and longevity research.

• 2018

  Foundation-based ownership model

  [3]Who is NAOS?naos.com

  Jean-Noël Thorel donated his shares in NAOS to the Jean-Noël Thorel Foundation, according to NAOS corporate materials.

• 2016

  Integration under NAOS

  [8]Creation of DIPTAnaos.com

  The activities of Bioderma, Institut Esthederm and Etat Pur were consolidated into the NAOS company structure.

• 2011

  Creation of Etat Pur

  [8]Creation of DIPTAnaos.com

  NAOS created Etat Pur as a personalized, biomimetic skincare brand, expanding the group’s portfolio beyond Bioderma and Institut Esthederm.

• 2001

  First foreign subsidiary

  [8]Creation of DIPTAnaos.com

  NAOS opened its first foreign subsidiary in Italy, beginning a broader international expansion for Bioderma and the group’s other brands.

• 1995

  Micellar technology and Sensibio H2O

  [8]Creation of DIPTAnaos.com

  Bioderma developed micellar technology and introduced Sensibio H2O, helping create the modern micellar cleansing-water category.

• 1988

  Aix-en-Provence laboratory platform

  [5]NAOS Les Laboratoiresnaos.com

  NAOS states that its independent laboratory has been based in Aix-en-Provence since 1988 and has served as the group’s principal design and production center.

• 1985

  Creation of DIPTA

  [8]Creation of DIPTAnaos.com

  DIPTA was created to support research, industrialization and manufacturing for Bioderma and Institut Esthederm.

• 1978

  Creation of Institut Esthederm

  [2]NAOS Our Storynaos.com

  Thorel created Institut Esthederm, the second brand associated with the business platform that later became NAOS.

• 1977

  Creation of the first Bioderma products

  [2]NAOS Our Storynaos.com

  Jean-Noël Thorel established the CEREDAP research center and created the first Bioderma products, beginning the brand’s dermatology and skin-biology orientation.

A pharmacy-oriented, science-led dermatological skincare brand positioned around skin biology, tolerance, barrier support and targeted care for specific skin conditions.

• Sensitive-skin care · 1995

  Sensibio

  Bioderma’s sensitive- and reactive-skin line. It includes cleansing waters, facial cleansers, eye-care products, moisturizers and soothing treatments intended to reduce discomfort while supporting tolerance. Sensibio H2O is the best-known product in the range and is associated with Bioderma’s micellar cleansing technology.

• Dry and very dry skin care

  Atoderm

  A body- and face-care range for dry, very dry and atopic-prone skin. Products include cleansing oils, shower products, emollient creams, balms and barrier-support treatments designed for regular care and for skin that is prone to dryness or discomfort.

• Acne-prone and oily-skin care

  Sébium

  A dermatological range for combination, oily and blemish-prone skin. The portfolio covers cleansing, exfoliation, moisturization, targeted blemish care and products intended to help manage excess sebum and visible imperfections.

• Dehydrated-skin care

  Hydrabio

  A hydration-focused line for dehydrated or moisture-deficient skin. It combines cleansing and moisturizing products intended to improve comfort, suppleness and the appearance of skin affected by environmental stress or impaired hydration.

• Repair and compromised-skin care

  Cicabio

  A line for irritated, weakened or compromised skin. Products are positioned around soothing, protective and restorative care for areas affected by dryness, friction, minor irritation or other situations in which the skin barrier requires support.

• Sun protection

  Photoderm

  Bioderma’s sun-care line, covering facial, body, children’s and specialized photoprotection products. The range is positioned around broad-spectrum protection and skin-specific formulations for different tolerability and exposure needs.

• Hair and scalp care

  Nodé

  A scalp- and hair-care range that includes shampoos and treatments for sensitive, dry, oily or dandruff-prone scalps. Nodé extends Bioderma’s dermatological approach from facial and body skin to the scalp ecosystem.

• Pediatric skincare

  ABCDerm

  A pediatric dermatological range for babies and children. It includes cleansing, moisturizing, protective and specialized products designed for developing skin and for common childhood skin-care needs.

• Pigmentation care

  Pigmentbio

  A range addressing uneven skin tone and hyperpigmentation concerns. Products are designed for routines involving cleansing, brightening, exfoliation, moisturization and protection against factors that can contribute to the appearance of dark spots.

• 2023Protection of Posidonia meadows

  France · International NAOS markets

  NAOS renewed a three-year partnership with Andromède Océanologie to support the protection and regeneration of Posidonia seagrass meadows, linking the group’s environmental commitments with its concern about aquatic ecosystems.

  Outcome. The partnership was renewed for a further three-year period according to NAOS.

  Source

• 2023

  Expansion of environmental commitmentsStrategy

  Background

  NAOS connected its ecobiological philosophy with concern for living ecosystems and the environmental effects of skincare products.

  Action taken

  The group promoted biodegradable rinse-off formulations, aquatic-ecosystem testing and support for Posidonia meadow protection.

  Aftermath

  Environmental stewardship became a more visible part of the corporate framework surrounding Bioderma and the other NAOS brands.

  Source

• 2018

  Transfer of NAOS shares to the Jean-Noël Thorel FoundationOther

  Background

  The founder sought to formalize NAOS as a company with an altruistic and long-term ownership model.

  Action taken

  Jean-Noël Thorel donated his shares in NAOS to the Jean-Noël Thorel Foundation.

  Aftermath

  NAOS continued to describe profits as being reinvested in the business or used to support health and human-development projects rather than distributed as conventional shareholder dividends.

  Source

• 2016

  Consolidation of three brands under NAOSStrategy

  Background

  Bioderma, Institut Esthederm and Etat Pur had developed as related but distinct brands within the same entrepreneurial group.

  Action taken

  Their activities were merged into a cohesive company structure called NAOS.

  Aftermath

  Bioderma retained its role as the dermatology-focused brand while benefiting from shared research, manufacturing and international infrastructure.

  Source

• 2001

  International subsidiary expansionStrategy

  Background

  After establishing its French dermatological platform, NAOS sought to broaden access to Bioderma through direct international operations.

  Action taken

  NAOS opened its first foreign subsidiary in Italy and subsequently expanded its network of affiliates and distributors.

  Aftermath

  Bioderma developed into an international pharmacy and dermocosmetics brand with distribution across multiple regions.

  Source

• 1995

  Launch of micellar cleansing technologyProduct launch

  Background

  Bioderma sought to create a cleansing product that could remove impurities and makeup while remaining suitable for sensitive skin.

  Action taken

  The brand developed micellar technology and launched Sensibio H2O, establishing a new product format in skincare.

  Aftermath

  Micellar water became a major skincare category, and Sensibio H2O became Bioderma’s most recognizable international offering.

  Source

1. 1Biodermaen.wikipedia.org
2. 2NAOS Our Storynaos.com
3. 3Who is NAOS?naos.com
4. 4The NAOS Dermatological Brandbioderma.us
5. 5NAOS Les Laboratoiresnaos.com
6. 6NAOS Care for the Livingnaos.com
7. 7The Foundernaos.com
8. 8Creation of DIPTAnaos.com